Measurement of basal growth hormone (GH) is a useful test of disease activity in treated acromegalic patients

Clinical Endocrinology

Volumn 68, Issue 1, 2008, Pages 36-41

  Jayasena, C N ^a   Wujanto, C ^a   Donaldson, M ^a   Todd, J F ^a   Meeran, K ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; HYDROCORTISONE; OCTREOTIDE; SOMATOMEDIN; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIAGNOSTIC TEST; DISEASE ACTIVITY; FEMALE; GROWTH HORMONE RELEASE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RELIABILITY;

ACROMEGALY; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 36949002732     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02996.x     Document Type: Article

References (27)

1. Nabarro, J.D.N. (1987) Acromegaly. Clinical Endocrinology, 26, 181 512.
2. Orme, S.M., McNally, R.J.Q., Cartwright, R.A. Belchetz, P.E. (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. Journal of Clinical Endocrinology and Metabolism, 83, 2730 2734.
3. Melmed, S., Casanueva, F., Cavagnini, F., Chanson, P., Frohman, L.A., Gaillard, R., Ghigo, E., Ho, K., Jaquet, P., Kleinberg, D., Lamberts, S., Laws, E., Lombardi, G., Sheppard, M.C., Thorner, M., Vance, M.L., Wass, J.A.H. Giustina, A. (2005) Consensus statement: medical management of acromegaly. European Journal of Endocrinology, 153, 737 740.
4. Duncan, E. Wass, J.A.H. (1999) Investigation protocol: acromegaly and its investigation. Clinical Endocrinology, 50, 285 293.
5. Giustina, A., Barkan, A., Casanueva, F., Cavagnini, F., Frohman, L., Ho, K., Veldhuis, J., Wass, J., Von Werder, K. Melmed, S. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526 529.
6. Colao, A., Pivonello, R., Cavallo, L.M., Gaccione, M., Auriemma, R.S., Esposito, F., Cappabianca, P. Gaetano, L. (2006) Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. Clinical Endocrinology, 65, 250 256.
7. Minuto, F., Resmini, E., Boschetti, M., Arvigo, M., Sormani, M.P., Giusti, M., Ferone, D. Barreca, A. (2004) Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion with the IGF system. Clinical Endocrinology, 61, 138 144.
8. Jenkins, D., O'Brien, I., Johnson, A., Shakespear, R., Sheppard, M.C. Stewart, P.M. (1995) The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly. Clinical Endocrinology, 53, 517 522.
9. Parfitt, V.J., Flanagan, D., Wood, P. Leatherdale, B.A. (1998) Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-I. Clinical Endocrinology, 49, 647 652.
10. Resmini, E., Barreca, A., Ferone, D., Giusti, M., Sidoti, M. Minuto, F. (2005) Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients. Clinical Endocrinology, 63, 294 297.
11. Alberti, K.G.M.M. Zimmet, P.Z. for the WHO Consultation 1998) Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine, 15, 539 553.
12. Barkan, A.L., Halasz, I., Dornfeld, K.J., Jaffe, C.A., Friberg, R.D., Chandler, W.F. Sandler, H.M. (1997) Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 82, 3187 3191.
13. Jenkins, P.J., Bates, P., Carson, M.N., Stewart, P.M. Wass, J.A.H. (2006) Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 91, 1239 1245.
14. Gutt, B., Hatzack, C., Morrison, K., Pollinger, B. Schopohl, J. (2001) Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly. European Journal of Endocrinology, 144, 109 116.
15. Barrande, G., Pittino-Lungo, M., Coste, J., Ponvert, D., Bertagna, X., Luton, J.P. Bertherat, J. (2000) Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. Journal of Clinical Endocrinology and Metabolism, 85, 3779 3785.
16. Freda, P.U. (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Hormone and IGF Research, 13, 171 184.
17. The Growth Hormone Research Society The Pituitary Society (2004) Biochemical assessment and long-term monitoring in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 3099 3102.
18. Freda, P.U., Nuruzzaman, A.T., Reyes, C.M., Sundeen, R.E. Post, K.D. (2004) Significance of 'abnormal' nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. Journal of Clinical Endocrinology and Metabolism, 89, 495 500.
19. Serri, O., Beauregard, C. Hardy, H. (2004) Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 658 661.
20. Bates, A., Evans, A., Jones, P. Clayton, R. (1995) Assessment of growth hormone status in acromegaly using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion. Clinical Endocrinology, 42, 417 423.
21. Freda, P., Post, K., Powell, J. Wardlaw, S. (1998) Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3808 3816.
22. Kaltsas, G.A., Isidori, A.M., Florakis, D., Trainer, P.J., Camacho-Hubner, C., Afshar, F., Sabin, I., Jenkins, J.P., Chew, S.L., Monson, J.P., Besser, G.M. Grossman, A.B. (2001) Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. Journal of Clinical Endocrinology and Metabolism, 86, 1645 1652.
23. Gullu, S., Keles, H., Delibasi, T., Tonyuku, V., Kamel, N. Erdogan, G. (2004) Remission criteria for the follow-up of patients with acromegaly. European Journal of Endocrinology, 150, 465 471.
24. Ayuk, J., Clayton, R., Holder, G., Sheppard, M., Stewart, P. Bates, A. (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 1613 1617.
25. Freda, P.U. (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Hormone and IGF Research, 13, 171 184.
26. Holdaway, I.M., Rajasoorya, C.R., Gamble, G.D. Stewart, A.W. (2003) Long-term treatment outcome in acromegaly. Growth Hormone and IGF Research, 13, 185 192.
27. Holdaway, I.M. Rajasoorya, C. (1999) Epidemiology of acromegaly. Pituitary, 2, 29 41.